Tradestie Institutional Equity Comparison Engine

ANRO vs IBO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IBO Overall Edge

IBO Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Impact BioMedical, Inc. (IBO) driven by superior Valuation, Growth & Margin, Momentum & Technical while ANRO counters with relative strength in Options & Structure. Fundamentally, ANRO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IBO at N/M Forward P/E and -12621.0% operating margin (+16.7% YoY). In options structure, ANRO sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against IBO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner IBO
ANRO N/M vs IBO N/M Fwd P/E
Growth & Margin Winner IBO
Op Margin 0.0% vs -12621.0% ยท YoY +0.0% vs +16.7%
Momentum & Technical Winner IBO
1Y +138.9% vs +862.8% ยท 52W Pos 61% vs 67%
Options & Structure Winner ANRO
CONSOLIDATION (8th %ile IV) vs UNCLASSIFIED (N/A IV)
ANRO NYSE
Alto Neuroscience Inc.
Pharmaceutical Preparations
$27.12
-8.19% 1D
Market Cap $1.2B
1M Return +23.61%
1Y Return +138.94%
Forward P/E N/M
Unified AI Score
29.3 / 100 SELL
Tech 50.0 Fund 34.0 Flow 65.0 Mom 40.0
IBO NYSE American
Impact BioMedical, Inc.
Pharmaceutical Preparations
$4.91
-4.47% 1D
Market Cap $44.4M
1M Return +83.21%
1Y Return +862.75%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 15.0 Fund 32.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ANRO +138.94% IBO +862.75% Spread: +723.81 pp (IBO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ANRO TTM Op. Margin: 0.0% IBO TTM Op. Margin: -12621.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANRO vs IBO. Trailing 12-month operating profitability (ANRO 0.0% vs IBO -12621.0%) and valuation multiples (ANRO N/M vs IBO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ANRO (3) vs IBO (6)
Institutional Metric ANRO IBO Criterion Row Winner
Market Capitalization Scale $1.2B $44.4M Larger Scale ANRO
Trailing P/E Ratio Valuation N/M 0.4x Lower Multiple IBO
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +16.7% Higher Growth IBO
Operating Margin (TTM) Profitability 0.0% -12621.0% Higher Margin ANRO
Net Profit Margin Profitability 0.0% 4247.4% Higher Margin IBO
Return on Equity (ROE) Capital Efficiency -46.7% 71.2% Higher ROE IBO
52-Week Range Position Momentum 61% ($11โ€“$37) 67% ($0โ€“$7) Stronger Trend IBO
Beta / 30D Volatility Risk Regime 1.95ฮฒ ยท 90% Vol -6.72ฮฒ ยท 120% Vol Lower Realized Risk ANRO
Unified Institutional Score Composite Signal 29.3 / 100 (SELL) 36.8 / 100 (SELL) Higher Composite IBO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ANRO vs IBO Buy Guide
ANRO CONSOLIDATION
57d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live ANRO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IBO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IBO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ANRO nor IBO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.